On FRIDAY night, NOVEMBER 7th, NephJC hosted another legendary NephJC Nights during ASN Kidney Week
Immune tolerance in kidney transplantation: from first principles to clinical engineering
Tolerancia inmunológica: ¿la quimera del trasplante renal? - El resumen visual
¿Qué significa estar libre de inmunosupresión en el trasplante renal?
Revisa el Resumen Visual por Bogdan Agavriloaei
Achieving immune tolerance by chimerism in kidney transplant
Is getting immunosuppression-free a chimera in kidney transplant?
Check out the visual abstract by Bogdan Agavriloaei
Chimerism and Immune Tolerance: Can We Says Goodbye to Immunosuppression?
ACC/AHA 2025 hypertension guidelines: what's new?
Check out the summary on AHA/ACC hypertension guidelines chat, done by NephJC intern Sridatta Pawar
ASIs Advance: NephJC Shorts on BaxHTN
NephJC 2025 Fall Pledge Drive
Guías AHA/ACC 2025 en Hipertensión: el resumen visual
La hipertensión arterial sigue siendo uno de los principales factores de riesgo modificables para enfermedad cardiovascular y enfermedad renal crónica. Las nuevas guías AHA/ACC 2025 han actualizado aspectos fundamentales sobre la prevención, la evaluación y el tratamiento de la hipertensión, con implicaciones directas para la práctica nefrológica.
Revisa el resumen visual creado por Dr Sejal Lakhani
visual abstract, Visual Abstract, sejal lakhani, Hypertension, HTN, ACC/AHA, 2025
The AHA/ACC 2025 Hypertension Guidelines visual abstract
New updated guidance on hypertension including screening for secondary causes, use of renal denervation, hypertension and pregnancy, risk assessment, monitoring and treatment.
Check out this wonderful VA by Dr Sejal Lakhani
PREVENT, Detect, Treat: What’s New in the 2025 Hypertension Toolkit
Hi or Lo phosphate targets in dialysis?
Check out the summary on HiLo chat, done by NephJC intern Shellie Fravel.
ACHIEVE the unchanged: dialysis mortality persists despite spironolactone
Check out the summary on ACHIEVE chat, done by NephJC intern Janany Sabescumar.
NephJC Shorts: MCD and FSGS Outcomes
NephJC Shorts: ALCHEMIST trial and Meta-analysis
ACHIEVE: el resumen visual
¿La espironolactona será la heroína que conquiste el corazón en hemodiálisis?
Descúbrelo en la travesía del ensayo ACHIEVE y únete a la discusión en #NephJC.
In ESRD is spironolactone an overACHIEVEr?
The ACHIEVE visual abstract
Does spironolactone decrease cardiovascular disease and heart failure hospitalizations in patients on dialysis?
Check out this crisp VA by Dr Akshaya Jayachandran.
#NephJC Summer Book Club Everything Is Tuberculosis poetry
#NephJC Summer Bookclub: Everything is Tuberculosis by John Green
The summer book club started in 2015, with one of the best books we have done in book club, Atul Gawande's Being Mortal. I think it should be required reading for all physicians. So now, in 2025, it is the NephJC Summer Book’s tenth anniversary (which represents our eleventh book). The history has been rich: